TY - JOUR
T1 - Left Atrial Appendage Closure
T2 - Prevention and Management of Periprocedural and Postprocedural Complications
AU - Wilkins, Ben
AU - Fukutomi, Motoki
AU - De Backer, Ole
AU - Søndergaard, Lars
N1 - Copyright © 2019 Elsevier Inc. All rights reserved.
PY - 2020/3
Y1 - 2020/3
N2 - Left atrial appendage closure (LAAC) is noninferior to oral vitamin K antagonist therapy for the reduction of nonvalvular atrial fibrillation-related stroke risk. Currently, the procedure is most widely accepted in patients who cannot tolerate oral anticoagulants. This patient population is generally comorbid, making any reduction in procedural complications paramount. LAAC has important complications described in the periprocedural and postprocedural periods. The prevention and management of complications regarding vascular access, transseptal puncture, pericardial effusion, device embolization, stroke, air embolusperidevice leak, device-related thrombus and device erosion/ late pericardial effusion are discussed.
AB - Left atrial appendage closure (LAAC) is noninferior to oral vitamin K antagonist therapy for the reduction of nonvalvular atrial fibrillation-related stroke risk. Currently, the procedure is most widely accepted in patients who cannot tolerate oral anticoagulants. This patient population is generally comorbid, making any reduction in procedural complications paramount. LAAC has important complications described in the periprocedural and postprocedural periods. The prevention and management of complications regarding vascular access, transseptal puncture, pericardial effusion, device embolization, stroke, air embolusperidevice leak, device-related thrombus and device erosion/ late pericardial effusion are discussed.
U2 - 10.1016/j.ccep.2019.10.003
DO - 10.1016/j.ccep.2019.10.003
M3 - Review
C2 - 32067649
SN - 1877-9182
VL - 12
SP - 67
EP - 75
JO - Cardiac electrophysiology clinics
JF - Cardiac electrophysiology clinics
IS - 1
ER -